Building Resilience for Advance Care Planning (ACP) in Chinese Americans
NCT ID: NCT06247215
Last Updated: 2026-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
125 participants
OBSERVATIONAL
2023-11-08
2025-12-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
1. How do religious leaders discuss advance care planning and death-related topics with Chinese Americans who are diagnosed with cancer or heart disease in Chicago?
2. Are Chinese Americans living in Chicago ready to participate in ACP discussions with their family?
3. What kind of support and resources are required to engage in end-of-life care discussions among Chinese Americans/immigrants living in Chicago?
4. What do Chinese Americans with cancer, high blood pressure, or heart disease and their family members think about an ACP pamphlet made for Chinese Americans?
Participants will share their experience either through interviews or a survey.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resilience in East Asian Immigrants for Advance Care Planning Discussions
NCT06035549
Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer
NCT02112188
CARE Study: Cancer, Asian Americans, and Relationship Enrichment
NCT06782581
Chinese American Cancer Survivors Writing Study
NCT05456100
Facilitating Advance Care Planning Discussions for People With Advanced Cancer
NCT06061965
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Religious Leaders
Religious leaders providing spiritual care to Chinese Americans
Religious leaders
Religious leaders who have experience providing pastoral or spiritual care to Chinese Americans living in Chicago
Chinese Americans living in Chicago
Chinese Americans living in Chicago
Chinese Americans
Chinese Americans living in Chicago.
Chinese Americans for end-of-life care discussions
Chinese Americans with experience in end-of-life care discussions
Chinese Americans with end-of-life care discussions
Chinese Americans who have experience discussing end-of-life care decisions with others.
Chinese Americans with chronic disease and their family members
Chinese Americans diagnosed with cancer, hypertension, or heart disease and their family members
Chinese Americans with chronic diseases
Chinese Americans who are diagnosed with cancer, hypertension, or heart disease and their family caregivers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Religious leaders
Religious leaders who have experience providing pastoral or spiritual care to Chinese Americans living in Chicago
Chinese Americans
Chinese Americans living in Chicago.
Chinese Americans with end-of-life care discussions
Chinese Americans who have experience discussing end-of-life care decisions with others.
Chinese Americans with chronic diseases
Chinese Americans who are diagnosed with cancer, hypertension, or heart disease and their family caregivers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having served as a chaplain, pastor, or monk at a health care setting or religious organization in Chicago;
* Being able to read and respond to questions in English or Mandarin;
* Having experience in having end-of-life discussions with Chinese Americans in Chicago.
* Age ≥ 18 years of age;
* Identifying themselves as first- or second-generation Chinese Americans;
* Being able to read and respond to questions in Mandarin or English.
* Age ≥ 18 years of age;
* Identifying themselves as first- or second-generation Chinese Americans;
* Having experience discussing end-of-life care decisions with others;
* Being able to read, write, and respond to questions in either English or Mandarin.
* Age ≥ 18 years of age;
* Self-identify themselves as first- or second-generation Chinese Americans/immigrants;
* Having a diagnosis of chronic diseases, such as cancer, hypertension, or heart disease;
* Being able to read and respond to questions in Mandarin;
* Being of the non-Hispanic Asian race/ethnicity.
* Age ≥ 18 years of age;
* Being able to read and respond to questions in Mandarin;
* Having a family member who is self-identified as a first or second-generation Chinese American/immigrant and has been diagnosed with chronic diseases, such as cancer, hypertension, or heart disease.
Exclusion Criteria
Group 3
Group 4
* Having cognitive impairment per a Short Portable Mental Status Questionnaire with more than 3 errors, or
* Being born in the US.
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Chicago
OTHER
Rush University Medical Center
OTHER
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
University of Illinois at Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Illinois Chicago
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-0354
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.